Arasho Belachew Degefe
Medical Faculty, Department of Neurology, Addis Ababa University, Addis Ababa, Ethiopia.
J Headache Pain. 2009 Feb;10(1):45-9. doi: 10.1007/s10194-008-0089-8. Epub 2009 Jan 8.
The International Headache Society (IHS) defines ophthalmoplegic migraine (OM) as recurrent attacks of headache with migrainous characteristics, associated with paresis of one or more ocular cranial nerves (commonly the third cranial nerve), and in the absence of any demonstrable intracranial lesion other than MRI changes within the affected nerve. According to the IHS criteria, it is diagnosed when at least two attacks with migraine-like headaches are accompanied with, or followed within 4 days of onset by, paresis of one or more of the third, fourth or sixth cranial nerves. Parasellar, orbital fissure and posterior fossa lesions should be ruled out by appropriate investigations. It is unlikely that OM is a variant of migraine, since the headache often lasts for a week or more and there is a latent period of up to 4 days from the onset of headache to the onset of ophthalmoplegia. Furthermore, in some cases MRI shows gadolinium uptake in the cisternal part of the affected cranial nerve and this suggests that the condition may be a recurrent demyelinating neuropathy. In general, patients demonstrated a: (1) prolonged time for symptom resolution to occur (median time 3 weeks); (2) tendency for recurrent episodes to have more severe and persistent nerve involvement; (3) evidence of permanent neurological sequelae with recurrent episodes (30% of patients); (4) rapid improvement and shortened duration with corticosteroid therapy and; (5) transient, reversible MRI contrast enhancement of the affected cranial nerve (86% of patients). Different pathogenetic mechanisms, which include compressive, ischemic and inflammatory, have been suggested for OM. Here, a 15-year-old Ethiopian with recurrent attacks of headache and third nerve palsy is presented. The subsequent discussion focuses on current evidences with regard to the clinical characteristics, possible pathogenetic mechanisms and treatment. Finally, a brief discussion of the situation in Africa will be presented.
国际头痛协会(IHS)将眼肌麻痹性偏头痛(OM)定义为具有偏头痛特征的复发性头痛发作,伴有一条或多条眼颅神经(通常是第三颅神经)麻痹,且除受累神经内的MRI改变外无任何可证实的颅内病变。根据IHS标准,当至少两次偏头痛样头痛发作伴有一条或多条第三、第四或第六颅神经麻痹,或在发病后4天内出现麻痹时,即可诊断。应通过适当检查排除鞍旁、眶裂和后颅窝病变。OM不太可能是偏头痛的一种变体,因为头痛通常持续一周或更长时间,从头痛发作到眼肌麻痹发作有长达4天的潜伏期。此外,在某些情况下,MRI显示受累颅神经脑池段有钆摄取,这表明该病可能是复发性脱髓鞘性神经病变。一般来说,患者表现出:(1)症状缓解时间延长(中位时间3周);(2)复发发作时神经受累更严重且持续的倾向;(3)复发发作时有永久性神经后遗症的证据(30%的患者);(4)皮质类固醇治疗后快速改善且病程缩短;(5)受累颅神经有短暂、可逆的MRI对比增强(86%的患者)。已提出OM有不同的发病机制,包括压迫性、缺血性和炎症性。本文介绍了一名15岁埃塞俄比亚人,有复发性头痛和第三神经麻痹发作。随后的讨论重点是关于临床特征、可能的发病机制和治疗的当前证据。最后,将简要讨论非洲的情况。